Urgent.News

One page, thousands of outlets. See who else covered it.

Editions

Health & Medicine

'Breakthrough' mRNA cancer drug cuts melanoma recurrence in major trial

WASHINGTON: US drugmakers Merck and Moderna said Wednesday a personalised cancer treatment had shown success in reducing the recurrence of melanoma tumors in a late-stage trial hailed by experts as a “breakthrough.”

'Breakthrough' mRNA cancer drug cuts melanoma recurrence in major trial

We haven't written up this one. New Straits Times has the full story — the link below goes straight to it.

Read the original at nst.com.my →

More in Health & Medicine

More from Thursday 20 August →